OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases
Jasvinder A. Singh
BioDrugs (2023) Vol. 37, Iss. 5, pp. 625-635
Closed Access | Times Cited: 7

Showing 7 citing articles:

Safety evaluation of deucravacitinib: a real-world analysis based on the FDA adverse event reporting system database
Haowen Tan, Xiubi Chen, Xuan Ou, et al.
Research Square (Research Square) (2025)
Closed Access

Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study
Léa Hoisnard, Antoine Meyer, Rosemary Dray‐Spira, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1364-1376
Closed Access | Times Cited: 3

Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.
Thomas G. Guilliams, Jill Weintraub, Myles Spar
PubMed (2024) Vol. 23, Iss. 5, pp. 16-26
Closed Access | Times Cited: 1

Case control study: G-allele of rs4244165 in JAK1 gene correlated with high-level brief psychiatric rating scale in bipolar patients
Akila Ahlem Elouaer Benkortbi Elouaer, Bochra Ben Mohamed, Férid Zaafrane, et al.
Medicine (2023) Vol. 102, Iss. 37, pp. e34652-e34652
Open Access | Times Cited: 1

Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
Theodoros Dimitroulas
Mediterranean Journal of Rheumatology (2023) Vol. 34, Iss. 3, pp. 282-282
Open Access | Times Cited: 1

JAK INHIBITORS IN THE TREATMENT OF SYSTEMIC VASCULITIDES
Fatma Alıbaz-Öner
Rheumatology Quarterly (2023)
Open Access

Page 1

Scroll to top